NYSE · TROX

TRONOX LIMITED CL A

$6.24 -$0.14 (-2.19%) 1D After hours
Charting by TradingView

Key Metrics

$1.02B
Market cap
—
P/E · TTM
$2.92B
Revenue · TTM
−$462.00M
Net income
EPS · TTM $-2.92
Dividend yield 5.5%
Free cash flow −$274.00M
Beta · 1Y 2.18
EBITDA · TTM −$150.00M
Gross margin 7.3%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    From its May 5 high, the share price fell 45%.

    Peak close $10.48 on May 5; trough close $5.77 on Jul 16. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -45%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 7
    The stock moved -16.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 7
  • Mar 17
    The stock moved +17.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 17

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$1.02B
Enterprise value$4.05B
Shares outstanding159.5M
52-wk range$2.86 – $10.59
Avg volume · 20D1.8M
Net cash −$3.04B
Book value / share$8.15
IndustryIndustrial Inorganic Chemicals
ExchangeNYSE
About TRONOX LIMITED CL A
IPO dateDec 1, 2010
Employees5750

Tronox Holdings PLC is a vertically integrated manufacturer of TiO2 pigment.

Wolf Grade COMING SOON

—

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E—
P/S0.35
P/FCF—
EV/EBITDA—
EV/Sales1.39
Graham №—

Profitability

Gross 7.3%
Operating -15.6%
Net -15.8%
FCF -9.4%
ROE / ROIC -30.3% · -10.8%

Financial Health

Current ratio2.42
Quick ratio0.66
Debt / equity2.45
Debt / EBITDA -21.09
Net cash −$3.04B
Working capital$1.27B

Cash Flow · TTM

Operating CF $24.00M
Capex −$298.00M
Free cash flow −$274.00M
Buybacks —
Dividends paid $56.00M
Shareholder yield 5.5%

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

0.6
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

—
Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings